本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CRISPR Therapeutics AG

62.94
+3.876.55%
盤前63.480.5400+0.86%05:22 EDT
成交量:279.25萬
成交額:1.73億
市值:57.24億
市盈率:-11.56
高:63.10
開:60.72
低:60.55
收:59.07
52周最高:71.13
52周最低:30.04
股本:9,095.04萬
流通股本:9,053.30萬
量比:1.00
換手率:3.08%
股息:- -
股息率:- -
每股收益(TTM):-5.4437
每股收益(LYR):-4.3416
淨資產收益率:-25.34%
總資產收益率:-13.05%
市淨率:3.35
市盈率(LYR):-14.50

資料載入中...

2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report